The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

26 May 2017 07:00

RNS Number : 3260G
Subex Limited
26 May 2017
 

 

 

 

 

 

 

 

 

 

May 26, 2017

 

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

Dear Sirs,

Sub: Outcome of the Board Meeting held on May 25, 2017

 

Please be informed that the agenda items stated hereunder were discussed and approved at the Board Meeting held on May 25, 2017 at Bangalore:

Ø Approval of the audited standalone and consolidated Financial Results of the Company for the quarter and year ended March 31, 2017.

Ø Approval of the audited standalone and consolidated Financial Statements of the Company for the year ended March 31, 2017.

Ø Appointment of Mr. Anil Singhvi as Chairman of the Company with effect from 25th May, 2017.

Ø Appointment of Mr. Vinod Kumar Padmanabhan and Mr. Ashwin Chalapathy as Whole-Time Directors (WTD) of the Company with effect from 25th May, 2017.

 

Please find enclosed:

Ø The consolidated Financial Results of the Company for the year ended March 31, 2017.

 

We request you to take the aforesaid notification on record.

 

 

Yours faithfully

For and on behalf of Subex Limited

 

Ganesh K V

Chief Financial Officer, Global Head -Legal and Company Secretary

 

 

 

 

SUBEX LIMITED

 

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

 

Statement of Audited Consolidated Financial Results for the quarter and year ended March 31, 2017

 

( Rs. in Lakhs)

Consolidated

Particulars

Quarter ended

Year ended

March 31, 2017

December 31, 2016

March 31, 2016

March 31, 2017

March 31, 2016

Audited (note 11)

Unaudited

Audited (note 11)

Audited

Audited

1

Income from operations

Net sales/ revenue from operations

9,485

9,578

8,926

35,733

32,246

Other income (note 8)

245

377

58

1,091

116

Total income from operations (net)

9,730

9,955

8,984

36,824

32,362

2

Expenses

(a)

Cost of hardware, software and support charges

204

194

(138)

694

42

(b)

Employee benefits expense (note 9)

3,582

4,047

4,262

15,871

16,034

(c)

Other expenditure

2,911

2,891

2,078

10,957

8,945

(d)

Depreciation and amortisation expense

139

127

110

495

427

(e)

Exchange fluctuation (gain)/loss (net)

647

(316)

(971)

(698)

515

Total expenses

7,483

6,943

5,341

27,319

25,963

3

Profit from operations before finance income, finance

2,247

3,012

3,643

9,505

6,399

costs and exceptional items (1-2)

4

Finance income

18

17

12

63

66

5

Profit from ordinary activities before finance costs and

2,265

3,029

3,655

9,568

6,465

exceptional items (3+4)

6

Finance costs

(a)

Interest on FCCBs (net)

106

126

486

494

3,754

(b)

Interest on term loan

-

96

254

464

974

(c)

Other finance costs

402

234

389

1,082

1,424

Total finance costs

508

456

1,129

2,040

6,152

7

Profit from ordinary activities before exceptional items

1,757

2,573

2,526

7,528

313

and tax (5-6)

8

Exceptional items (net) (note 5)

(10,890)

-

(6,469)

(10,890)

(6,469)

9

Net (loss) / profit from ordinary activities before tax(7+8)

(9,133)

2,573

(3,943)

(3,362)

(6,156)

10

Tax expense (net)

237

318

186

961

1,273

11

Net (loss)/ profit for the period / year (9-10)

(9,370)

2,255

(4,129)

(4,323)

(7,429)

12 Other comprehensive income, net of taxes

275

(561)

(957)

(1,376)

(1,833)

13

Total comprehensive income (11+12)

(9,095)

1,694

(5,086)

(5,699)

(9,262)

14

Paid up equity share capital (face value of ` 10 (March 31,

50,691

50,691

50,281

50,691

50,281

2016: ` 10)

15

Other equity

-

-

-

17,718

23,102

 

16 Earnings/(loss) per share (of ` 10/- each) (not annualised in case of the interim periods):

 

(a)

- Basic

(1.85)

0.44

(0.97)

(0.85)

(2.56)

(b)

- Diluted

(1.85)

0.44

(0.97)

(0.85)

(2.56)

SUBEX LIMITED

 

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

 

Statement of Consolidated Assets and Liabilities

 

( Rs. in Lakhs)

Particulars

As at

March 31, 2017

March 31, 2016

A

Audited

Audited

ASSETS

Non-current assets

Property, plant and equipment

785

648

Goodwill on consolidation

65,882

76,772

Other intangible assets

138

82

Financial assets

Loans

399

365

Other balances with banks

258

238

Other financial assets

234

235

Income tax asset (net)

1,977

1,665

Deferred tax asset (MAT credit entitlement)

478

384

Other non-current assets

564

617

Current assets

70,715

81,006

Financial assets

Loans

196

199

Trade receivables

11,851

11,148

Cash and cash equivalents

7,386

8,600

Other financial assets

4,508

2,551

Other current assets

1,013

707

24,954

23,205

Total Assets

95,669

104,211

B

EQUITY AND LIABILITIES

Equity

Equity share capital

50,691

50,281

Other equity

17,718

23,102

Total equity

68,409

73,383

Liabilities

Non-current liabilities

Financial liabilities

Borrowings

-

4,057

Other financial liabilities

-

571

Provisions

297

295

Current liabilities

297

4,923

Financial liabilities

Borrowings

8,590

10,396

Trade payable

1,805

1,676

Other financial liabilities

11,922

9,967

Other current liabilities

3,085

2,435

Provisions

677

653

Income tax liabilities (net)

884

778

26,963

25,905

Total liabilities

27,260

30,828

Total equity and liabilities

95,669

104,211

Notes:

 

1 The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on May 25, 2017.

 

2 The financial results of Subex Limited (Standalone information):

 

( Rs. in Lakhs)

Quarter ended

Year ended

March 31, 2017

December 31, 2016

March 31, 2016

March 31, 2017

March 31, 2016

Particulars

Audited (note 11)

Unaudited

Audited (note 11)

Audited

Audited

Total income from operations (net)

8,779

9,067

8,282

33,479

29,624

Profit/(loss) from ordinary activities before tax

(3,239)

1,763

(17,678)

(429)

(20,464)

Profit/(loss) from ordinary activities after tax

(3,353)

1,712

(17,695)

(683)

(20,998)

 

3 The financial results have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ("Ind AS") prescribed under section 133 of the Companies Act, 2013, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016.

 

4 Reconciliation between previous GAAP and Ind AS

 

Consequent to transition from the previous GAAP to Ind AS, the reconciliation of profit/loss after tax for the corresponding three months and year ended March 31, 2016 and reconciliation of equity as on March 31, 2016 is provided below:

 

(a)

Financial results reconciliation:

( Rs. in Lakhs)

Quarter ended

Year ended March

Particulars

March 31, 2016

31, 2016

Net (loss) /profit under previous GAAP

(1,151)

5,872

Add/(less): Ind AS adjustments income/(loss):

(i) Measurement of Foreign Currency Convertible Bonds ('FCCBs') at fair value

(a) Impact on finance cost due to effective interest rate and transfer of interest no longer payable to retained earnings on

(2,965)

(11,891)

conversion of FCCBs into equity shares

(b) Impact on foreign exchange due to change in carrying value of FCCBs and related account balances and transfer of

(418)

(1,846)

exchange gain to retained earnings on conversion of FCCBs into equity shares

(ii) Impact of deferral of revenue pertaining to free support services

(61)

(33)

(iii) Impact on measurement of other long term borrowings at fair value

431

431

(iv) Others (net)

35

38

Net loss after tax as per Ind AS

(4,129)

(7,429)

(b)

Equity reconciliation:

( Rs. in Lakhs)

Particulars

As on

March 31, 2016

Equity as reported under previous GAAP

72,700

Effect of transition to Ind AS

(i) Impact on measurement of long term borrowings at fair value:

(a) Foreign Currency Convertible Bonds

387

(b) Other term loans

466

(ii) Impact of deferral of revenue pertaining to free support services

(233)

(iii) Others (net)

63

Equity as per Ind AS

73,383

5 Exceptional items:

( Rs. in Lakhs)

Quarter ended

Year ended

Particulars

March 31, 2017

December 31, 2016

March 31, 2016

March 31, 2017

March 31, 2016

Audited (note 11)

Unaudited

Audited (note 11)

Audited

Audited

i. Loss on impairment of goodwill (note 5[i](a) & (b))

(10,890)

-

(8,870)

(10,890)

(8,870)

ii. Reversal of interest accrued but not due pertaining to term

-

-

2,401

-

2,401

loans (note 5[ii])

Total

(10,890)

-

(6,469)

(10,890)

(6,469)

 

5[i][a] As at March 31, 2017, the Company assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex Americas Inc., amounting to ` 9,736 Lakhs (March 31, 2016: ` 18,606 Lakhs). Based on future operational plan, projected cash flows and valuation carried out by an external valuer, the Company has made an impairment provision of ` 6,010 Lakhs (March 31, 2016: ` 8,870 Lakhs) towards the carrying value of goodwill relating to its investment in the said subsidiary. The management is of the view that, the carrying value of goodwill relating to its investment in the said subsidiary of ` 3,726 Lakhs as at March 31, 2017 is appropriate.

 

5[i][b] As at March 31, 2017, the Company assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex (UK) Limited amounting to ` 67,036 Lakhs (March 31, 2016: ` 67,036 Lakhs). Based on future operational plan, projected cash flows and valuation carried out by an external valuer, the Company has made an impairment provision of ` 4,880 Lakhs (March 31, 2016: ` Nil) towards the carrying value of goodwill relating to its investment in the said subsidiary. The management is of the view that, the carrying value of goodwill relating to its investment in the said subsidiary of ` 62,156 Lakhs as at March 31, 2017 is appropriate.

 

5[ii] During the year ended March 31, 2016, pursuant to the QVT Interest Waiver Letter dated March 26, 2016, the lenders of term loan of US$ 12 Million to Subex Americas Inc. had waived the interest liability upto the date of such letter and interest accruing thereafter upto August 22, 2016. Further, interest rate has been revised from 10.5% per annum to 5% per annum, effective August 22, 2016. Consequently, accrued outstanding interest of US$ 2.9 Million ( ` 1,970 Lakhs) has been written back and impact on measurement of such long term borrowings at fair value resulted in reduction in carrying value by ` 431 Lakhs as at March 31, 2016. During the current year ended March 31, 2017, such interest waiver has been extended till June 30, 2017 and subsequent to the year end, the entire loan of US$ 12 Million has been repaid as on May 15, 2017.

 

6 Subsequent to balance sheet date, the Company has made an allotment of 55,094,999 equity shares of the Company on a preferential basis, at an issue price of ` 14 per equity share (Face value of ` 10 per equity share) amounting to ` 7,713 Lakhs.

 

7 (a) As at March 31, 2017, the Company has outstanding FCCBs III of USD 3.60 Million ( ` 2,335 Lakhs) which are carried at fair value of USD 3.51 Million ( ` 2,277 Lakhs) in the books of accounts, which are due for redemption on July 07, 2017.

 

(b) The FCCB holders in their respective meetings have approved the deferral of aggregate interest of US$ 0.73 Million ( ` 473 Lakhs) in respect of outstanding FCCBs III with face value of US$ 3.60 Million ( ` 2,335 Lakhs) for the period July 6, 2012 to January 5, 2016 till redemption date of the bonds, being July 07, 2017.

 

8 The Company had remitted the withholding taxes on interest on FCCBs III in accordance with the provisions of the Income Tax Act, 1961 amounting to ` 1,052 Lakhs pertaining to FCCBs III which have been converted into equity shares of the Company. Pursuant to such conversion, the interest accrued but not due is considered no longer payable and the management basis expert advice, is of the view that the withholding taxes paid by the Company in respect of the aforesaid interest, are recoverable from income tax department and/or are adjustable against its other withholding taxes obligations. Accordingly, the Company has revised the returns of withholding taxes and adjusted withholding taxes of ` 205 Lakhs during the quarter ended March 31, 2017 (quarter ended December 31, 2016 and March 31, 2016 amounting to ` 377 Lakhs and ` Nil, respectively and that for the year ended March 31, 2017 and March 31, 2016 amounting to ` 1,037 Lakhs and ` Nil, respectively) on salary, professional services and others by write back of withholding taxes on interest on FCCBs paid earlier, and such write back is included under other income.

 

9 Employee benefits expenses for the quarters ended March 31, 2017, December 31, 2016 and March 31, 2016 are net of reversal of provision no longer required, in respect of employee incentives relating to sales and delivery commissions, amounting to ` 700 Lakhs, ` Nil and ` 192 Lakhs, respectively and that for the year ended March 31, 2017 and March 31, 2016 amounting to ` 700 Lakhs and ` 1,065 Lakhs, respectively.

 

10 The Group is engaged in the business of software products and related services. These, in the context of Ind AS 108 on Operating Segments Reporting are considered to constitute one segment and hence the Group has not made any additional segment disclosures.

 

11 The figures of last quarter of current and previous year are the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures of nine months of respective year.

 

12 Previous period figures have been regrouped/ reclassified, wherever necessary to confirm to current period's/ year's classification.

 

13 Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

 

 

Bengaluru

Surjeet Singh

Date: May 25, 2017

Managing Director & CEO

For further details on the results, please visit our website: www.subex.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR GSGDUSSDBGRL
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.